Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV: Effect of Everolimus and CNI Minimalization on Renal Function.

NCT00596557 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT00596557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00596557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV: Effect of Everolimus and CNI Minimalization on Renal Function.
Lead sponsor
Rabin Medical Center
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rejection of cardiac transplant